Michael F. Evans
About
In The Last Decade
Michael F. Evans
27 papers receiving 368 citations
Peers
Comparison fields: 5 of 95
- General Health Professions 100
- Cardiology and Cardiovascular Medicine 84
- Orthopedics and Sports Medicine 71
- Public Health, Environmental and Occupational Health 60
- Surgery 49
Countries citing papers authored by Michael F. Evans
This map shows the geographic impact of Michael F. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Evans more than expected).
Fields of papers citing papers by Michael F. Evans
This network shows the impact of papers produced by Michael F. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Evans. The network helps show where Michael F. Evans may publish in the future.
Co-authorship network of co-authors of Michael F. Evans
This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Evans. A scholar is included among the top collaborators of Michael F. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Evans. Michael F. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 32 | |
| 3 | 30 | |
| 4 | 23 | |
| 5 | 35 | |
| 6 | The waiting room "wait": from annoyance to opportunity. | 35 |
| 7 | 17 | |
| 8 | Lose weight to lose erectile dysfunction. | 4 |
| 9 | 42 | |
| 10 | Lifestyle intervention or treatment with metformin. Which delays onset of type 2 diabetes? | 2 |
| 11 | Can we prevent high-risk patients from getting type 2 diabetes? | 2 |
| 12 | Taking NSAIDs during pregnancy. Is it safe? | 1 |
| 13 | Role of glucocorticoids in treating croup. | 2 |
| 14 | Gabapentin or amitriptyline for painful diabetic neuropathy? | 4 |
| 15 | Diagnosing abdominal aortic aneurysm. How good is the physical examination? | 4 |
| 16 | Omeprazole or misoprostol. Which works best for NSAID-induced ulcers? | 1 |
| 17 | Clinical practice guidelines for the diagnosis and management of osteoporosis | 93 |
| 18 | Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. | 4 |
| 19 | Critical appraisal and Canadian Family Physician. | 1 |
| 20 | Zinc gluconate lozenges for treating the common cold. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.